ClariVest Asset Management’s Kura Oncology KURA Stock Holding History

ClariVest Asset Management’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-24,948	Closed	-$520K	–	792
2021 Q2	$520K	Buy	24,948 +60	+0.2%	+$1.49K	0.02%	426
2021 Q1	$704K	Sell	24,888 -14,900	-37%	-$471K	0.02%	347
2020 Q4	$1.3M	Sell	39,788 -38,598	-49%	-$1.36M	0.04%	245
2020 Q3	$2.4M	Sell	78,386 -3,747	-5%	-$82.7K	0.08%	198
2020 Q2	$1.34M	Sell	82,133 -21,341	-21%	-$308K	0.04%	283
2020 Q1	$1.03M	Buy	103,474 +5,843	+6%	+$66.9K	0.03%	290
2019 Q4	$1.34M	Sell	97,631 -45,342	-32%	-$672K	0.03%	312
2019 Q3	$2.17M	Buy	142,973 +116,273	+435%	+$2.07M	0.05%	249
2019 Q2	$526K	Buy	+26,700	New	+$443K	0.01%	363

Other funds holding KURA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ClariVest Asset Management's KURA Position: Q3 2021 in Review

ClariVest Asset Management sold out of Kura Oncology (KURA) in Q3 2021, closing a stake of 24,948 shares — an estimated $520K sold.

ClariVest Asset Management first reported a position in KURA in Q2 2019 and held it in 9 quarters. The position peaked at $2.4M in Q3 2020. 152 funds tracked by Wall St. Rank hold KURA as of Q3 2021.

ClariVest Asset Management reported no remaining Kura Oncology position as of Q3 2021 after selling out during the quarter.
ClariVest Asset Management sold 24,948 Kura Oncology shares in Q3 2021, an estimated $520K.
ClariVest Asset Management first reported a position in Kura Oncology in Q2 2019 and held it in 9 quarters.
ClariVest Asset Management's Kura Oncology position peaked at $2.4M in Q3 2020.
152 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2021.

Based on ClariVest Asset Management's 13F filing for Q3 2021, filed 8 Nov 2021.